Czech court cancels for second time ruling that acquits former Prime Minister Babiš of fraud charges
PRAGUE (AP) — Prague's High Court canceled for the second time on Monday a lower court ruling that acquitted former Prime Minister Andrej Babiš of fraud charges in a $2 million case involving a European Union subsidy.
The court returned the case for retrial to Prague's Municipal Court to deal with it, saying the lower court, which acquitted Babiš for the second time last year, did not properly assess evidence.
Babiš had pleaded not guilty and repeatedly said the charges against him were politically motivated. The prosecution had originally requested a suspended sentence and a fine to be paid by the populist billionaire who left the courtroom before the verdict was announced.
The municipal court acquitted Babis for the first time in 2023. Prague's High Court later canceled that decision and ordered the case to be retried at the same court.
Babiš' former associate Jana Nagyová, who signed the subsidy request, will also face retrial.
The case centered around a farm known as the Stork's Nest, which received EU subsidies after its ownership was transferred from the Babiš-owned Agrofert conglomerate of around 250 companies to Babis' family members. Later, Agrofert again took ownership of the farm.
The subsidies were meant for medium- and small-sized businesses, which Agrofert wouldn't have been eligible for. The conglomerate later returned the subsidy.
The lower court previously said what Babiš did was not considered criminal.
Babi has become part of the country's opposition after his populist ANO (YES) centrist movement lost the 2021 parliamentary election. He also contended for the largely ceremonial post of president in January 2023 but lost to Petr Pavel, a retired army general.
Monday's verdict comes just months before October's parliamentary election in which Babiš and his movement are predicted to win the vote.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
44 minutes ago
- Bloomberg
Dutch Minister Calls Iran Crisis a Wake-Up Call on NATO Spending
US strikes on Iranian nuclear sites and Russia's continued war in Ukraine should act as a wake-up call for NATO to boost defense spending, the Dutch defense minister said. They show 'how our security is at stake and in what an unstable environment and the unstable world we live in,' Ruben Brekelmans, 38, said in an interview in The Hague on Monday. 'What we are working on is strengthening our collective defense and deterrence.'


Associated Press
an hour ago
- Associated Press
Benchmark Data for Dealmakers - Access Deal Records of Actual Deals As Disclosed by the Deal Parties
DUBLIN--(BUSINESS WIRE)--Jun 23, 2025-- The 'Precision Medicine Collaboration and Licensing Deals 2019-2025" has been added to offering. This report contains a comprehensive listing of 1,221 precision medicine deals announced since 2019, including financial terms where available, and links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the world's leading biopharma companies. Fully revised and updated, the report provides details of precision medicine deals from 2019 to 2025. The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research, and licensing deals. The initial chapters of the report offer an overview of precision medicine dealmaking. Chapter 1 serves as an introduction, while Chapter 2 outlines the trends in precision medicine dealmaking since 2019. Chapter 3 highlights leading precision medicine deals by headline value, and Chapter 4 lists the top 25 most active companies with summaries and listings of deals. Chapters 5 and 6 provide detailed reviews of deals announced since Jan 2019, organized by contractor availability and technology focus respectively. Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits: Precision Medicine Collaboration and Licensing Deals includes: Analyzing contract agreements allows due diligence of: Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in precision medicine dealmaking 2.1. Introduction 2.2. Precision medicine deals over the years 2.3. Most active precision medicine dealmakers 2.4. Precision medicine deals by deal type 2.5. Precision medicine deals by therapy area 2.6. Precision medicine deals by industry sector 2.7. Deal terms for precision medicine deals 2.7.1 Precision medicine deals headline values 2.7.2 Precision medicine deal upfront payments 2.7.3 Precision medicine deal milestone payments 2.7.4 Precision medicine royalty rates Chapter 3 - Leading precision medicine deals 3.1. Introduction 3.2. Top precision medicine deals by value Chapter 4 - Most active precision medicine dealmakers 4.1. Introduction 4.2. Most active precision medicine dealmakers 4.3. Most active precision medicine deals company profiles Chapter 5 - Precision medicine contracts dealmaking directory 5.1. Introduction 5.2. Precision medicine contracts dealmaking directory Chapter 6 - Precision medicine dealmaking by technology type Deal directory Companies Featured For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/23/2025 01:09 PM/DISC: 06/23/2025 01:08 PM


Bloomberg
an hour ago
- Bloomberg
Malaysian Fryer Oil Arbitrage
You can make jet fuel from palm oil. It doesn't even need to be fresh. You can take palm oil, put it in a deep fryer, use it to make french fries, reuse it again and again until it becomes gross and the fries taste bad, and then take the used oil and sell it to a refiner to make jet fuel. Also works with olive oil, soybean oil, lots of cooking oils. This is a very nice fact about the world! You can get jet fuel without (1) drilling for oil or (2) cutting down forests to create dedicated agricultural land just for the jet fuel. You use the existing agricultural land to make cooking oil, you cook with it until it's no longer good, and then when you are done with it you get an extra bonus use as jet fuel. In 2025, this extra bonus use is especially valuable, because energy companies and airlines, at least in Europe, want to demonstrate that they are environmentally sustainable. So finding an environmentally sustainable way to make jet fuel is worth a lot of money to them. Therefore they will pay a lot of money for used cooking oil (or 'UCO').